Sokmen Bedriye Koyuncu, Sokmen Dogukan, Ucar Nese, Ozkurt Huseyin, Simsek Abdulmuttalip
Department of Radiology, Sisli Florence Nightingale Hospital Istanbul.
Arch Ital Urol Androl. 2017 Dec 31;89(4):277-281. doi: 10.4081/aiua.2017.4.277.
Firstly, we aimed to investigate the correlation among dynamic contrasted magnetic resonance (MR) images, diffusion-weighted MR images, and apparent diffusion coefficent (ADC) values in patients with prostate cancer. Secondly, we aimed to investigate the roles of these variables on clinical risk classification and the biological behavior of the prostate cancer.
A total of sixty with prostatic adenocarcinoma patients diagnosed between January 2011 and May 2013 were retrospectively included in the study. Risk classification of patients were evaluated as low-risk (Group 1) (n = 20) (Stage T1c-T2a, PSA < 10 ng/ml, Gleason Score < 7), moderate-risk (Group 2) (n = 18) (Stage T1b-T2c, PSA = 10-20 ng/ml, Gleason Score = 7) and high-risk (Group 3) (n = 22) (Stage > T3a, PSA > 20 ng/ml, Gleason Score > 7). Diffusion-weighted MR images, dynamic contrasted MR images, and ADC values of the prostates were correlated.
ADC values of the cases in Group 3 were lower than those of the other groups (p < 0.001). ADC values of the areas without malignancy did not differ significantly between groups (p > 0.05). Biological activity of the tumor tissue was determined by GS, while a negative correlation was observed between GSs and ADC values of the patients, (p < 0.001).
In tumors with higher Gleason scores, lower ADC values were obtained. These measured values can play a role in the noninvasive determination of the cellularity of the tumoral mass.
首先,我们旨在研究前列腺癌患者的动态对比磁共振(MR)图像、扩散加权MR图像和表观扩散系数(ADC)值之间的相关性。其次,我们旨在研究这些变量在前列腺癌临床风险分类和生物学行为中的作用。
回顾性纳入2011年1月至2013年5月期间诊断的60例前列腺腺癌患者。患者的风险分类评估为低风险(第1组)(n = 20)(T1c - T2a期,PSA < 10 ng/ml,Gleason评分 < 7)、中度风险(第2组)(n = 18)(T1b - T2c期,PSA = 10 - 20 ng/ml,Gleason评分 = 7)和高风险(第3组)(n = 22)(T3a期以上,PSA > 20 ng/ml,Gleason评分 > 7)。对前列腺的扩散加权MR图像、动态对比MR图像和ADC值进行相关性分析。
第3组病例的ADC值低于其他组(p < 0.001)。各组间无恶性病变区域的ADC值差异无统计学意义(p > 0.05)。肿瘤组织的生物学活性由GS确定,患者的GS与ADC值之间呈负相关(p < 0.001)。
在Gleason评分较高的肿瘤中,ADC值较低。这些测量值可在无创确定肿瘤块细胞密度中发挥作用。